EC and Pembrolizumb combination therapy with Pegfilgrastim as primary preventio
Not Applicable
Recruiting
- Conditions
- triple negative breast cancer being treated by preoperative chemotherapy
- Registration Number
- JPRN-UMIN000053351
- Lead Sponsor
- Hyogo Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Those who not gave written informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method